IconMEX:ICLRN 87 ROA % is 2.57% as of Mar. 2026, which is 65% below its 10-year median of 7.38. GuruFocus rates MEX:ICLRN with a GF Score™ of 87/100 and a GF Value™ of MXN2,479.74. The stock has 4 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Icon ranks better than 59.53% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Icon's annualizedNet Income for the quarter that ended in Mar. 2026 was MXN7,556 Mil.
Icon's average Total Assets over the quarter that ended in Mar. 2026 was MXN293,612 Mil. Therefore, Icon's annualized ROA % for the quarter that ended in Mar. 2026 was 2.57%.
The historical rank and industry rank for Icon's ROA % or its related term are showing as below:
MEX:ICLRN'
s ROA % Range Over the Past 10 Years
Min: 0.93 Med: 7.38 Max: 14.8
Current: 0.93
During the past 13 years, Icon's highest ROA % was 14.80%. The lowest was 0.93%. And the median was 7.38%.
MEX:ICLRN's ROA % is ranked better than 59.53% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.87
vs MEX:ICLRN: 0.93
Icon (MEX:ICLRN) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Icon ROA % Related Terms
Icon ROA % Historical Data
* Premium members only.
The historical data trend for Icon's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Icon's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Icon ROA % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Icon's ROA % distribution charts can be found below:
* The bar in red indicates where Icon's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Icon (MEX:ICLRN) has a ROA % of 2.57% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Icon and its competitors. This is 65% below median its historical median of 7.38. Over the past decade, Icon's ROA % has ranged from 0.93 to 14.80. According to the industry distribution chart, Icon ranks #87 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 40.5%.
Is Icon's ROA % too high?
Icon's current ROA % of 2.57% is 65% below median its 10-year median of 7.38. Over the past 10 years, this metric has ranged from a low of 0.93 to a high of 14.80. Based on the distribution chart, Icon ranks #87 out of 215 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Icon has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Icon's ROA % compare to RVTY and CRL?
According to the Medical Diagnostics & Research industry distribution chart, Icon ranks #87 out of 215 companies for ROA %. This puts Icon in the upper half of its industry. Historically, Icon's own ROA % has ranged from 0.93 to 14.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Diagnostics & Research company?
A good ROA % depends on the Medical Diagnostics & Research industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Icon and its competitors. Icon's current ROA % is 2.57%, which is 65% below median its own 10-year median of 7.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icon stock overvalued right now?
Icon (MEX:ICLRN) has a current ROA % of 2.57%. The stock's GF Value™ is MXN2,479.74, compared to a current price of MXN1,850.28 — trading 25.4% below its estimated fair value. The current ROA % is 2.57%, which is 65% below median its 10-year median of 7.38. Icon's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Icon (MEX:ICLRN), the current ROA % is 2.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Icon (MEX:ICLRN) Overvalued in 2026?
Based on GuruFocus' analysis, Icon stock appears to be undervalued.
The current stock price of MXN1,850.28 is trading 25.4% below its estimated GF Value™ of MXN2,479.74.
Key valuation signals for MEX:ICLRN:
ROA %: 2.57% (65% below median its 10-year median of 7.38)
GF Value™: MXN2,479.74 vs. price of MXN1,850.28 (25.4% below fair value)
No single metric tells the full story. See the MEX:ICLRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
87GF Score
Get the complete analysis for MEX:ICLRN
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ICLRN has been successfully added to your 
